MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4161/hv.35859

Медицинская библиотека · Human vaccines & immunotherapeutics · 2014

The burden of disease of Herpes Zoster in Tuscany.

Levi Miriam, Bellini Irene, Capecchi Leonardo, Pieri Luca, Bechini Angela, Boccalini Sara, Callaioli Silvia, Gasparini Roberto, Panatto Donatella, Tiscione Emilia, Bonanni Paolo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Herpes zoster (HZ) is a disease caused by the reactivation of the latent α-herpes virus varicella zoster virus (VZV), for which, in Italy, a specific surveillance system does not exist, but around 200 000 cases are estimated each year. In older patients, who are at increased risk of developing HZ, symptoms are more severe and the chances to develop postherpetic neuralgia (PHN), the most severe complication, are substantially higher. A vaccine against HZ with demonstrated efficacy and an acceptable safety profile is now available and is recommended in Europe for adults >50 years.   In anticipation of the possible introduction of an immunization programme for the elderly in Tuscany, the burden of disease caused by HZ and its complications was assessed through a retrospective analysis of the hospital discharge records between 2002 and 2012, using the ICD-9-CM 053 code. In the period 2002-2012, 4475 hospital admissions were registered with annual means of 368 hospitalizations and 39 day-hospital admissions. Most of the hospitalizations (68%) involved subjects > 65 years; the mean length of stay was 9.5 days. Slightly more than half (51.2%) of total hospital admissions were complicated cases. The most frequent were neurological complications (24.2% of total admissions), followed by ophthalmic complications (16.5%). Cases with neurological complications were those with the higher average length of stay and higher average costs for case. This study confirmed the epidemiological impact of HZ and its complications and the positive impact on morbidity that the introduction of the HZ vaccination could have in older age groups.

Для цитирования: Levi Miriam, Bellini Irene, Capecchi Leonardo, Pieri Luca, Bechini Angela, Boccalini Sara, Callaioli Silvia, Gasparini Roberto, Panatto Donatella, Tiscione Emilia, Bonanni Paolo. The burden of disease of Herpes Zoster in Tuscany.. Human vaccines & immunotherapeutics. 2014. DOI: 10.4161/hv.35859.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.